CEO, Pharmaceutical Segment
Mon, Nov 27, 2023
Nov 27
5,990 shares @ $0.00
Decreased holdings by -100.00%
21st largest trade (out of 31)
Option Exercise
Trade made by an officer
Sale tied to a same-time option exercise
Price 23% above 200-day moving average